title: Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy.
authors: University of Florida College of Medicine-Jacksonville, Jacksonville, Florida 32209, USA.
authors: José Luis
authors: JL
authors: Ferreiro
authors: Masafumi
authors: M
authors: Ueno
authors: Antonio
authors: A
authors: Tello-Montoliu
authors: Salvatore D
authors: SD
authors: Tomasello
authors: Naveen
authors: N
authors: Seecheran
authors: Bhaloo
authors: B
authors: Desai
authors: Fabiana
authors: F
authors: Rollini
authors: Luis A
authors: LA
authors: Guzman
authors: Theodore A
authors: TA
authors: Bass
authors: Dominick J
authors: DJ
authors: Angiolillo
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000628:therapy*; D000244:Adenosine Diphosphate; D015415:Biomarkers / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D015815:Cell Adhesion Molecules / Q000097:blood; D016009:Chi-Square Distribution; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006801:Humans; D008840:Microfilament Proteins / Q000097:blood; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects; D010750:Phosphoproteins / Q000097:blood; D010766:Phosphorylation; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D010979:Platelet Function Tests; D000068799:Prasugrel Hydrochloride; D011446:Prospective Studies; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D058925:Receptors, Purinergic P2Y12 / Q000097:blood / Q000187:drug effects; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D016896:Treatment Outcome; D000098662:Vasodilator-Stimulated Phosphoprotein
chemical_list: D015415:Biomarkers; D015815:Cell Adhesion Molecules; D008840:Microfilament Proteins; C548576:P2RY12 protein, human; D010750:Phosphoproteins; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D013876:Thiophenes; D000098662:Vasodilator-Stimulated Phosphoprotein; D000244:Adenosine Diphosphate; D000068799:Prasugrel Hydrochloride